Search Results - "tyrosine kinase"

Neurotrophin-3 and FLT3 Tyrosine Kinase Receptor in Perinatal Life by Ariadne Malamitsi-Puchner, Emmanouel Economou, Theodora Boutsikou, Konstantinos E. Nikolaou, Nikolaos Vrachnis

Connect to this object online.

Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors by Maddalena Centanni, Lena E. Friberg

Connect to this object online.

Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors by Jaehee V. Shim, Jaehee V. Shim, Yuguang Xiong, Yuguang Xiong, Priyanka Dhanan, Rafael Dariolli, Rafael Dariolli, Evren U. Azeloglu, Evren U. Azeloglu, Bin Hu, Bin Hu, Gomathi Jayaraman, Gomathi Jayaraman, Christoph Schaniel, Marc R. Birtwistle, Ravi Iyengar, Ravi Iyengar, Nicole C. Dubois, Eric A. Sobie, Eric A. Sobie

Connect to this object online.

Active receptor tyrosine kinases, but not Brachyury, are sufficient to trigger chordoma in zebrafish by Gianluca D'Agati, Elena María Cabello, Karl Frontzek, Elisabeth J. Rushing, Robin Klemm, Mark D. Robinson, Richard M. White, Christian Mosimann, Alexa Burger

Connect to this object online.

Tyrosine kinase inhibitors induced scrotal ulcerations: Report of 2 cases by Abhipsa Samal, Nibedita Dixit, Bikash R Kar, Liza Mohapatra

Connect to this object online.

Cardiovascular safety of tyrosine kinase inhibitors: Putting their "QT-phobia" in perspective by Rashmi Shah

Connect to this object online.

Bruton's tyrosine kinase inhibitor associated localized extremity edema and erythema by Shannon Meledathu, BS, Paul Chu, MD, Tatyana Feldman, MD, Andre Henri Goy, MD, Rachel Kushner Rosenstein, MD, PhD

Connect to this object online.

Therapeutic choices in patients with Ph-Positive chronic myelogenous leukemia in Mexico in the era of tyrosine kinase inhibitors: stem cell transplantation or tyrosine kinase inhibitors?... by Max Robles-Nasta, Daniela Sánchez-Bonilla, Moises M. Gallardo-Pérez, Edgar J. Hernández-Flores, Merittzel A. Montes-Robles, María de L. Pastelín-Martínez, Juan C. Olivares-Gazca, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles

Connect to this object online.

Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis by Franziska Paech, Franziska Paech, Jamal Bouitbir, Jamal Bouitbir, Jamal Bouitbir, Stephan Krähenbühl, Stephan Krähenbühl, Stephan Krähenbühl

Connect to this object online.

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects by Shan Jing, Yang Lin, Randy Dockens, David Marchisin, Bing He, Ihab G. Girgis, Anjaneya Chimalakonda, Bindu Murthy, Urvi Aras

Connect to this object online.

Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer by Desh Deepak Singh, Hae-Jeung Lee, Dharmendra Kumar Yadav

Connect to this object online.

Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors by Maddalena Centanni, Abel Thijs, Ingrid Desar, Mats O. Karlsson, Lena E. Friberg

Connect to this object online.

Effect of tyrosine kinase inhibitors on the cytotoxic activity against HIV-1 infection by S. Rodríguez-Mora, G. Bautista, E. Mateos, V. García, J.L. Steegmann, J. Ambrosioni, Nuria Climent, F. Cervantes, J.M. Miró, M. Plana, J. Alcamí, M. Coiras

Connect to this object online.

Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential by José Rivera-Torres, Esther San José

Connect to this object online.

Receptor tyrosine kinases as a therapeutic target by natural compounds in cancer treatment by Toheeb A. Balogun, Oluwasegun M. Ige, Abdullahi O. Alausa, Chijioke O. Onyeani, Zainab A. Tiamiyu, Damilola A. Omoboyowa, Oluwatosin A. Saibu, Olayemi T. Abdullateef

Connect to this object online.

Lichen planopilaris-like eruption during treatment with tyrosine kinase inhibitor nilotinib by Juliana Ribeiro Leitão, Neusa Yuriko Sakai Valente, Priscila Kakizaki, Isis Suga Veronez, Mario Cezar Pires

Connect to this object online.

Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment by Pitsiou G, Zarogoulidis P, Petridis D, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Papaiwannou A, Tsiouda T, Hohenforst-Schmidt W, Kakolyris S, Syrigos K, Huang H, Li Q, Turner JF, Zarogoulidis K

Connect to this object online.

The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Impairs the Vascular Development of Zebrafish Larvae by Kun Wang, Qiushi Xu, Hanbing Zhong

Connect to this object online.

Selective inhibition of N-linked glycosylation impairs receptor tyrosine kinase processing by Elsenoor Klaver, Peng Zhao, Melanie May, Heather Flanagan-Steet, Hudson H. Freeze, Reid Gilmore, Lance Wells, Joseph Contessa, Richard Steet

Connect to this object online.

Bruton's Tyrosine Kinase in Neutrophils Is Crucial for Host Defense against Klebsiella pneumoniae by Zhe Liu, Alexander P.N.A. De Porto, Regina De Beer, Joris J.T.H. Roelofs, Onno J. De Boer, Sandrine Florquin, Cornelis Van't Veer, Rudi W. Hendriks, Tom Van der Poll, Alex F. De Vos

Connect to this object online.